Skip to content

Prophylactic Sodium Supplementation for Children Hospitalized With Pneumonia

Impact of Prophylactic Sodium Supplementation on Hospital Outcomes in Infants and Children With Pneumonia. A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06951347
Enrollment
140
Registered
2025-04-30
Start date
2025-05-01
Completion date
2025-06-05
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Pneumonia

Brief summary

The goal of this clinical trial is to study the impact of sodium supplementation on hospital outcomes of children with pneumonia. It aims to answer: * Does sodium supplementation lower the length of hospital stay in children with pneumonia? * Does potassium supplementation lower the length of hospital stay in children with pneumonia? Researchers will compare the intervention arm to the control arm to see if the intervention lowers the length of hospital stay. Participants will: • Take one sachet of oral rehydration solution (ORS) every day for 3 days.

Detailed description

The study is a randomized clinical trial that will be conducted on hospitalized children with pneumonia after considering exclusion criteria. The enrolled children will be randomly divided into two groups: the intervention group and the control group. The intervention group will receive the ORS daily for 3 days. All children will be followed until discharge from the hospital, and their clinical outcomes will be assessed.

Interventions

DIETARY_SUPPLEMENTOral Rehydration Solution

one sachet every day for 3 days

Sponsors

General Organization for Teaching Hospitals and Institutes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Months to 5 Years
Healthy volunteers
No

Inclusion criteria

* Infants and children aged between 1 month and 5 years. * Patients diagnosed with pneumonia according to World Health Organization (WHO) criteria.

Exclusion criteria

* Children with other comorbidities. * Those whose parents will show disapproval for the participation of the study. * Children on medications that affect sodium and potassium levels.

Design outcomes

Primary

MeasureTime frameDescription
The difference in hospital length of stay between hospitalized children with pneumonia who received oral rehydration solution and those who did not receive itChildren will be followed until discharge from the hospital, an average of one week.Evaluation of effect of oral rehydration solution supplementation by assessing the length of hospital stay

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026